For research use only. Not for therapeutic Use.
Buclazide (Cat. No: I014280) is clinically used as a piperazine antihistamine for acute or chronic urticaria, eczema, dermatitis and other allergic skin diseases. It can also be used for motion sickness, insomnia, anxiety, etc.
| Catalog Number | I014280 |
| CAS Number | 82-95-1 |
| Synonyms | Buclizine; Histabutizine; Histabutyzine;Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)- (9CI) |
| Molecular Formula | C28H33ClN2 |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| Solubility | Soluble in DMSO |
| InChI | InChI=1S/C28H33ClN2/c1-28(2,3)25-13-9-22(10-14-25)21-30-17-19-31(20-18-30)27(23-7-5-4-6-8-23)24-11-15-26(29)16-12-24/h4-16,27H,17-21H2,1-3H3 |
| InChIKey | MOYGZHXDRJNJEP-UHFFFAOYSA-N |
| SMILES | CC(C1=CC=C(CN2CCN(C(C3=CC=C(Cl)C=C3)C4=CC=CC=C4)CC2)C=C1)(C)C |
| Reference | </br> 1: Seo EJ, Fischer N, Efferth T. Role of TCTP for Cellular Differentiation and Cancer Therapy. Results Probl Cell Differ. 2017;64:263-281. doi: 10.1007/978-3-319-67591-6_14. PubMed PMID: 29149414.</br>2: Seo EJ, Efferth T. Interaction of antihistaminic drugs with human translationally controlled tumor protein (TCTP) as novel approach for differentiation therapy. Oncotarget. 2016 Mar 29;7(13):16818-39. doi: 10.18632/oncotarget.7605. PubMed PMID: 26921194; PubMed Central PMCID: PMC4941353.</br>3: Borukhova S, Noël T, Hessel V. Continuous-Flow Multistep Synthesis of Cinnarizine, Cyclizine, and a Buclizine Derivative from Bulk Alcohols. ChemSusChem. 2016 Jan 8;9(1):67-74. doi: 10.1002/cssc.201501367. Epub 2015 Dec 9. PubMed PMID: 26663906.</br>4: Kuminek G, Stulzer HK, Tagliari MP, Oliveira PR, Bernardi LS, Rauber GS, Cardoso SG. High-performance column liquid chromatographic method for the simultaneous determination of buclizine, tryptophan, pyridoxine, and cyanocobalamin in tablets and oral suspension. J AOAC Int. 2011 Nov-Dec;94(6):1785-90. PubMed PMID: 22320085.</br>5: Babu TA. Buclizine is back again! This time as a pediatric appetite stimulant. Indian J Pharmacol. 2011 Apr;43(2):219. doi: 10.4103/0253-7613.77383. PubMed PMID: 21572667; PubMed Central PMCID: PMC3081471.</br>6: Mostafa GA, Al-Badr AA. Buclizine. Profiles Drug Subst Excip Relat Methodol. 2011;36:1-33. doi: 10.1016/B978-0-12-387667-6.00001-4. Epub 2011 Jun 23. PubMed PMID: 22469258.</br>7: Arayne MS, Sultana N, Mirza AZ, Siddiqui FA. Simultaneous determination of gliquidone, fexofenadine, buclizine, and levocetirizine in dosage formulation and human serum by RP-HPLC. J Chromatogr Sci. 2010 May-Jun;48(5):382-5. PubMed PMID: 20515533.</br>8: Arayne MS, Sultana N, Siddiqui FA. Quantitation of buclizine hydrochloride in pharmaceutical formulations and human serum by RP-HPLC. Pak J Pharm Sci. 2006 Oct;19(4):326-9. PubMed PMID: 17105713.</br>9: El Walily AF, El Gindy A, Bedair MF. Application of first-derivative UV-spectrophotometry, TLC-densitometry and liquid chromatography for the simultaneous determination of mebeverine hydrochloride and sulpiride. J Pharm Biomed Anal. 1999 Nov;21(3):535-48. PubMed PMID: 10701420.</br>10: Fischer MJ, Paulussen JJ, Horbach DA, Roelofsen EP, van Miltenburg JC, de Mol NJ, Janssen LH. Inhibition of mediator release in RBL-2H3 cells by some H1-antagonist derived anti-allergic drugs: relation to lipophilicity and membrane effects. Inflamm Res. 1995 Feb;44(2):92-7. PubMed PMID: 7655991.</br>11: Adam EI. A treatment for the acute migraine attack. J Int Med Res. 1987 Mar-Apr;15(2):71-5. PubMed PMID: 3556262.</br>12: Behrendt WA, Cserepes J. Acute toxicity and analgesic action of a combination of buclizine, codeine and paracetamol (‘Migraleve’) in tablet and suppository form in rats. Pharmatherapeutica. 1985;4(5):322-31. PubMed PMID: 4070325.</br>13: Burgess HA, Merrington DM, Oliver WJ, Thomson A, Rogers HJ. The relative bioavailability of paracetamol after rectal administration of suppositories containing a mixture of paracetamol, codeine phosphate and buclizine hydrochloride in healthy volunteers. Curr Med Res Opin. 1985;9(9):634-41. PubMed PMID: 3902377.</br>14: Persaud N, Johnson ES, Merrington D, Oliver W. The relative bioavailability of paracetamol and codeine after oral administration of a combination of buclizine, paracetamol and codeine, with or without docusate, and of paracetamol alone in healthy volunteers. Curr Med Res Opin. 1985;9(9):626-33. PubMed PMID: 2414066.</br>15: Novack GD, Stark LG, Peterson SL. Anticonvulsant effects of benzhydryl piperazines on maximal electroshock seizures in rats. J Pharmacol Exp Ther. 1979 Mar;208(3):480-4. PubMed PMID: 34712.</br>16: Jorgensen PB, Weightman D, Foster JB. Comparison of migraleve and buclizine in prophylaxis of migraine. Curr Ther Res Clin Exp. 1974 Dec;16(12):1276-80. PubMed PMID: 4218156.</br>17: Kulkarni SD, Joglekar GV, Balwani JH. Anabolic activity of buclizine on rats. Eur J Pharmacol. 1972 Feb;17(2):312-4. PubMed PMID: 4402100.</br>18: Hermans W. [Clinical evaluation of buclizine for underweight patients]. Brux Med. 1971 Apr;51(4):295-8. French. PubMed PMID: 4931282.</br>19: Bormans A. [Double-blind study of the eutrophic effect of buclizine on children]. Brux Med. 1971 Apr;51(4):291-3. French. PubMed PMID: 4931281.</br>20: Lamy F. [Appetite stimulation and weight increase with buclizine]. Brux Med. 1971 Apr;51(4):287-90. French. PubMed PMID: 4931280.</br></br> |
